Clinical Trial Update: Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice

View source ↗

Summary

A completed observational study in Italian patients with heart failure with reduced ejection fraction evaluating real-world use of dapagliflozin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Heart Failure, Reduced Ejection Fraction | Status: COMPLETED